LAG-3 is regarded as a prospective therapeutic target for tumor immunotherapy since several studies have demonstrated a correlation between high levels of LAG-3 expression with tumor growth and prognosis in a variety of human tumor types [72,73]. The gene discussed is LAG3; the disease is neoplasm.